| Product Name | MF | CAS | Details |
|---|
| H-GAPINSATAM-OH | Details |
| 5-[5-N-(Phthaloyl)amino-4-oxo-pentanoyloxy]-4-oxo-pentanoic acid methyl ester | Details |
| H-DLLGLCEQK^-OH | Details |
| 1-Ethyl-3,5-dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | C13H23BN2O2 | 1082503-79-4 | Details |
| MAL-dPEG?4-t-boc-Hydrazide | C18H34O11 | 94376-75-7 | Details |
| 4-Bromoisoquinoline-6-carboxylic acid | C10H6BrNO2 | 1637280-23-9 | Details |
| 3,3'-(2,7-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-fluorene-9,9-diyl)bis(N,N-dimethylpropan-1-amine) | C35H54B2N2O4 | 953390-94-8 | Details |
| 3-[(3-Aminophenyl)formamido]propanamide hydrochloride | C10H14ClN3O2 | 1258641-50-7 | Details |
| Chebulagic acid | C41H30O27 | 23094-71-5 | Details |
| BMS 641988 | C20H20F3N3O5S | 573738-99-5 | Details |
| HNF4 alpha antibody | Details |
| H-LQGTLPVEAR^-OH | Details |
| H-RLLFRKIRRLKR-OH | Details |
| 2-[4-[[3-(4-Bromophenyl)-1-oxo-2-propenyl]amino]-3-fluorophenyl]-5-benzoxazoleacetic acid | C24H16BrFN2O4 | 853929-59-6 | Details |
| Desfluoro ciprofloxacin hydrochloride | C17H19N3O3 | 93107-11-0 | Details |
| 4-(Methoxymethyl)-4-methylpiperidine | C8H17NO | 774224-63-4 | Details |
| Acetyl coenzyme A lithium | C23H39LiN7O17P3S | 32140-51-5 | Details |
| 7-Fluoro-5-nitro-1H-indole | C8H5FN2O2 | 1167055-33-5 | Details |
| 6-Amino-1-methyl-2,3-dihydro-1H-1,3-benzodiazol-2-one hydrochloride | C8H10ClN3O | 879658-18-1 | Details |
| 5-(Trifluoromethyl)-1,3-thiazole-4-carboxylic acid | C5H2F3NO2S | 900530-68-9 | Details |
| LRG antibody | Details |
| Fmoc-Homoarg(Pbf)-OH | C35H42N4O7S | 1159680-21-3 | Details |
| Ambroxol HCl - Bio-X ? | C13H19Br2ClN2O | 23828-92-4 | Details |
| tert-Butyl (3R)-3-amino-3-methylpyrrolidine-1-carboxylate | C10H20N2O2 | 1817789-07-3 | Details |
| 4,4-Difluorocyclohexan-1-one | C6H8F2O | 22515-18-0 | Details |
| Mouse IL12 ELISA Kit (p70) | Details |
| 2-Fluoro-3-methoxyaniline | C7H8FNO | 801282-00-8 | Details |
| Methyl 2-cyclohexylideneacetate | C9H14O2 | 40203-74-5 | Details |
| (2-Ethylphenyl)methanamine | C9H13N | 53759-86-7 | Details |
| 2-Methoxy-3-thiophenecarboxaldehyde | C6H6O2S | 41057-07-2 | Details |
| Vatinoxan hydrochloride | C20H27ClN4O4S | 130466-38-5 | Details |
| 6-Bromo-5-fluoropyridine-2-carbaldehyde | C6H3BrFNO | 1227605-60-8 | Details |
| 6-Cyclopropyl-3-phenyl-[1,2]oxazolo[5,4-b]pyridine-4-carboxylic acid | C16H12N2O3 | 953733-48-7 | Details |
| PKC-theta inhibitor | C20H25F3N6O3 | 736048-65-0 | Details |
| 3-Bromo-5H,6H,8H-imidazo[2,1-c][1,4]oxazine | C6H7BrN2O | 1505641-47-3 | Details |
| 2-Bromo-1,3-bis(difluoromethyl)benzene | C8H5BrF4 | 79839-50-2 | Details |
| 4-{6-Chloro-[1,2,4]triazolo[4,3-b]pyridazin-3-yl}pyridine | C10H6ClN5 | 1032705-69-3 | Details |
| TentaGel??S CHO | Details |
| BDNF antibody | Details |
| RPS5 antibody | Details |
| Methyl azido acetate | C3H5N3O2 | 1816-92-8 | Details |
| 2,2,4,6-Tetramethyl-1,3-dioxan-5-one | 1824560-60-2 | Details |
| (1S)-1-(3,4-Dichlorophenyl)ethanamine Hydrochloride | C8H10Cl3N | 823790-74-5 | Details |
| Calystegine N1 | C7H14N2O3 | 177794-03-5 | Details |
| 3-(Azetidin-3-yl)-2,3-dihydro-1,3-benzoxazol-2-one hydrochloride | C10H11ClN2O2 | 1864059-79-9 | Details |
| IDI1 antibody | Details |
| 1-Benzyl-1H-imidazo[4,5-c]pyridin-4-amine | C13H12N4 | 1782814-98-5 | Details |
| Butyl 2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-b-D-glucopyranoside | C18H29NO9 | 155197-37-8 | Details |
| Methyl 1-benzyl-3-hydroxy-1H-pyrrole-2-carboxylate | C13H13NO3 | 1782533-38-3 | Details |
| Methyl 5-oxospiro[2.3]hexane-1-carboxylate | C8H10O3 | 1518220-73-9 | Details |
| H-LVFFAEDVGSDK-OH | Details |
| N,3-Dimethyl-4-nitroaniline | C8H10N2O2 | 52177-10-3 | Details |
| 2-methoxy-6-(trifluoromethyl)isonicotinic acid | C8H6F3NO3 | 1227581-20-5 | Details |
| 4-Methylcyclohexaneacetic acid, mixture of cis and trans | C9H16O2 | 6603-71-0 | Details |
| 3-(4-Bromophenyl)-4,5-dihydro-1,2-oxazole | C9H8BrNO | 51067-06-2 | Details |
| 2-(Dimethyl-1,2-oxazol-4-yl)propanoic acid | C8H11NO3 | 897008-27-4 | Details |
| (-)-Grindelic acid | C20H32O3 | 1438-57-9 | Details |
| Uracil-5,6-d2 | C4H2D2N2O2 | 24897-52-7 | Details |
| rac-(1R,2R,4S)-2-(Aminomethyl)bicyclo[2.2.1]heptan-2-ol hydrochloride | 40344-80-7 | Details |
| 1-(1H-Indazole-6-carbonyl)piperidine-2-carboxylic acid | C14H15N3O3 | 1218555-39-5 | Details |
| Recombinant Human MIF | Details |
| Showdomycin | C9H11NO6 | 16755-07-0 | Details |
| 2-Methyl-2-phenylpentan-3-ol | C12H18O | 88790-27-6 | Details |
| 3-(Propane-2-sulfonyl)pyrrolidine hydrochloride | C7H16ClNO2S | 1864064-35-6 | Details |
| 2-[5-(Phenoxymethyl)-2H-1,2,3,4-tetrazol-2-yl]acetic acid | C10H10N4O3 | 871497-68-6 | Details |
| 2-(1H-Pyrazol-1-yl)benzaldehyde | C10H8N2O | 138479-47-7 | Details |
| MAGEB4 Blocking Peptide | Details |
| 2-Isopropyl-6-propylphenol | C12H18O | 74663-48-2 | Details |
| Longistyline A | C20H22O2 | 64095-60-9 | Details |
| Mono(2-ethylhexyl) terephthalate | C16H22O4 | 155603-50-2 | Details |
| 3’-O-tert-butyldimethylsilyl-5’-O-DMT-N1-methylpseudouridine | C37H46N2O8Si | 875302-43-5 | Details |
| Anxa1 protein (His tag) | Details |
| tert-Butyl 5-formylthiazol-2-ylcarbamate | C9H12N2O3S | 391668-77-2 | Details |
| 2-Methyl-6-(morpholin-4-yl)pyridin-3-amine | C10H15N3O | 221159-08-6 | Details |
| PYGL antibody | Details |
| Enrofloxacin-OVA | Details |
| 3-Methoxy-1-benzofuran-2-carbonitrile | C10H7NO2 | 84748-24-3 | Details |
| Ethyl 2-[3-(3-hydroxyazetidin-1-yl)oxetan-3-yl]acetate | C10H17NO4 | 1207175-27-6 | Details |
| Methyl 4-(aminomethyl)-5-methylthiophene-2-carboxylate hydrochloride | 2193059-15-1 | Details |
| Benzyl N-[(2S)-1-(chlorosulfonyl)propan-2-yl]carbamate | C11H14ClNO4S | 1140948-95-3 | Details |
| Neuropeptide FF (5-8) acetate salt | C25H39N9O5 | 152050-35-6 | Details |
| 2-[(3-Chlorophenyl)(cyanomethyl)amino]acetic acid | C10H9ClN2O2 | 1179673-92-7 | Details |
| 1-Chloro-3-fluoro-5-methyl-2-nitrobenzene | C7H5ClFNO2 | 1805526-89-9 | Details |
| 3-(1-Methyl-1H-imidazol-2-yl)propan-1-ol | C7H12N2O | 136609-58-0 | Details |
| 2-Ethoxy-N-(5-nitro-1,3-thiazol-2-yl)benzamide | C12H11N3O4S | 333442-05-0 | Details |
| 7-Chloro-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride | C10H13Cl2N | 23166-82-7 | Details |
| 2-(chloromethyl)-5-(3-methoxyphenyl)-1,3,4-oxadiazole | C10H9ClN2O2 | 36770-18-0 | Details |
| (2-Methoxyphenyl)(pyridin-2-yl)methanol | C13H13NO2 | 27652-91-1 | Details |
| KCTD15 protein (His tag) | Details |
| 2,5-Dimethyl-1H-imidazole-4-carboxylic acid hydrochloride | C6H9ClN2O2 | 1820684-42-1 | Details |
| 5-Chloro-2-methoxy-3-nitrobenzoic acid | C8H6ClNO5 | 89894-14-4 | Details |
| 3-Cyclohexanecarbonylpyridine | C12H15NO | 60148-00-7 | Details |
| 1-[(2,2,2-Trifluoroethoxy)methyl]-1H-pyrazol-4-amine hydrochloride | C6H9ClF3N3O | 1185098-59-2 | Details |
| 5-Methylbenzofuran | C9H8O | 18441-43-5 | Details |
| 1,2-Dimethylcyclohexan-1-amine | C8H17N | 39077-52-6 | Details |
| 6-(1-Methyl-1H-pyrazol-4-yl)pyridin-3-ol | C9H9N3O | 1256371-63-7 | Details |
| Gliclazide impurity F | C15H21N3O3S | 1076198-18-9 | Details |
| H-CINGACWTV-OH | Details |
| 2-Chloro-6-(pyrrolidin-1-yl)benzaldehyde | C11H12ClNO | 110405-86-2 | Details |
| 2,3,4,5-Tetrahydro-1-benzothiepine-7-carboxylic acid | C11H12O2S | 226259-91-2 | Details |
| Product Total： Product Page： | ||||
| 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 | ||||